Skip to content
Clinical Trials – home
Varsinais-Suomen hyvinvointialue
Sponsor

Varsinais-Suomen hyvinvointialue

Finland Kiinamyllynkatu 4-8, 20520 Turku, Finland

About the sponsor

Research activity includes neonatal brain perfusion, cerebral elasticity, and early-life brain injury in newborns with hypoxic-ischemic, infectious, and ischemic conditions. The sponsor also studies maternal immunisation and the longer-term immune effects of pertussis vaccination in children.

  • Neonatal cerebral imaging
  • Brain perfusion assessment
  • Maternal and childhood pertussis immunity

These studies reflect interest in early diagnostic evaluation of the developing brain and in immune protection during pregnancy and early childhood.

About Specializations

Varsinais-Suomen hyvinvointialue runs clinical trials in conditions such as Multiple sclerosis, Pertussis immunisation, Rectal cancer, Metastases to lymph nodes, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

9 clinical trials

Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Sponsor:Varsinais-Suomen hyvinvointialue

Depression

Not yet recruiting
Registered drug
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Propofol
  • Sponsor:Varsinais-Suomen hyvinvointialue
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:[Al[18F]F]Fapi-74
  • Sponsor:Varsinais-Suomen hyvinvointialue
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Hydroxychloroquine Sulfate
  • Sponsor:Varsinais-Suomen hyvinvointialue

Colitis ulcerative+1

Not yet recruiting
Registered drug
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Infliximab
  • Sponsor:Varsinais-Suomen hyvinvointialue
Countries:FinlandFinland
  • Participants:0–17 years
  • Substances:Sulfur Hexafluoride
  • Sponsor:Varsinais-Suomen hyvinvointialue
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:TETANUS TOXOID
  • Sponsor:Varsinais-Suomen hyvinvointialue
Registered drug
Countries:FinlandFinland
  • Participants:0–17 years · 18–64 years · Healthy volunteers
  • Sponsor:Varsinais-Suomen hyvinvointialue

Multiple sclerosis

Not recruiting
Registered drug
Countries:FinlandFinland
  • Participants:18–64 years
  • Substances:Cladribine
  • Sponsor:Varsinais-Suomen hyvinvointialue

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).